Skip to main content

Table 3 Diagnostic accuracy of BFS

From: Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis

BFS cutoff point

Accuracy

%

SN

SP

PPV

NPV

LR + 

LR-

≥ 0.10

54.1

82.4

97.0

26.9

45.7

93.9

1.3

0.1

≥ 0.20

62.4

71.8

93.9

42.3

50.8

91.7

1.6

0.1

≥ 0.30

70.6

51.8

78.8

65.4

59.1

82.9

2.3

0.3

≥ 0.40

76.5

43.5

75.8

76.9

67.6

83.3

3.3

0.3

≥ 0.46

78.8

36.5

69.7

84.6

74.2

81.5

4.5

0.4

≥ 0.50

77.6

35.3

66.7

84.6

73.3

80.0

4.3

0.4

≥ 0.60

72.9

25.9

48.5

88.5

72.7

73.0

4.2

0.6

≥ 0.70

70.6

14.1

30.3

96.2

83.3

68.5

8.0

0.7

≥ 0.80

65.9

9.4

18.2

96.2

75.0

64.9

4.8

0.9

≥ 0.90

62.3

1.2

3.0

100

100

61.9

-

1.0

  1. BFS BMP8A fibrosis score, % number of patients with BFS ≥ cut-off point, SN Sensitivity, SP Specificity, PPV Positive predictive value, NPV Negative predictive value, LR + positive likelihood ratio, LR- Negative likelihood ratio